Used as an intermediate in the synthesis of pharmaceuticals, particularly in the production of chiral compounds for drug development. Its fluorinated structure enhances metabolic stability and bioavailability in active pharmaceutical ingredients. Commonly employed in the preparation of beta-hydroxy esters used in antidiabetic and antihypertensive agents. Also serves as a building block in asymmetric synthesis due to the presence of both hydroxyl and ester functional groups, enabling selective transformations. Widely utilized in research settings for developing novel fluorinated molecules with improved pharmacokinetic properties.